F. Buttitta et al., P53 NUCLEAR ACCUMULATION IN PRENEOPLASTIC LESIONS AND STAGE-I UTERINEENDOMETRIOID ADENOCARCINOMA, Oncology Reports, 4(2), 1997, pp. 315-318
A total of 118 endometrial neoplastic and preneoplastic lesions compri
sing 43 uterine endometrioid adenocarcinoma at stage I, 40 complex (ad
enomatous) hyperplasias and 35 atypical hyperplasias were examined for
p53 nuclear accumulation to assess the incidence of p53 alterations i
n infiltrating carcinomas and to verify if p53 aberrations may allow t
he identification of a subset of premalignant cases with high risk of
progression. No specific immunostaining was observed in the cases of c
omplex hyperplasia without atypias. One (3%) of 35 atypical hyperplasi
as showed focal areas of p53 immuno-reactivity. The overall frequency
of p53 overexpression in endometrial carcinomas was 54%. The distribut
ion of cases with nuclear accumulation of p53 was significantly differ
ent (p=0.01) in tumours with different degree of invasiveness. In addi
tion, p53 nuclear accumulation was observed more often in tumours with
moderate (G2) or poor differentiation (G3) (p=0.03). Our data indicat
e that p53 aberrations are not early events in endometrial carcinogene
sis and may be related with tumour progression and aggressiveness.